Vicarious Surgical to Present at the Cowen 6th Annual FutureHealth Conference on June 17th

Rhea-AI Summary

Vicarious Surgical, a pioneer in surgical robotics, announces participation in the Cowen 6th Annual FutureHealth Conference on June 17, 2021. CEO Adam Sachs will engage in a fireside chat at 10:00 a.m. ET. The event aims to showcase the company's innovative approach to enhancing surgical efficiency and patient outcomes through proprietary technology. Vicarious Surgical, established in 2014, has gained FDA's Breakthrough Device Designation, marking it as the first surgical robot to achieve this recognition. The live webcast will be available on their website.

WALTHAM, Mass., June 11, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve cost, efficiency, and outcomes of surgical procedures, today announced that Adam Sachs, the Chief Executive Officer of Vicarious Surgical, will participate in the Cowen 6th Annual FutureHealth Conference, which will be held virtually from June 16th-17th.  Mr. Sachs will participate in a fireside chat on Thursday, June 17th at 10:00 a.m. Eastern Time.

A live audio webcast of the presentation will be accessible to the public on the Company's website at https://www.vicarioussurgical.com/. An archive of the webcast will be available for replay following the conference.

About Vicarious Surgical

Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the definitive goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company's novel surgical approach uses a combination of proprietary human-like surgical robots and head mounted display to virtually transport surgeons inside the patient to perform minimally invasive surgery. The Company's technology was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), making it the first, and only, surgical robot to receive this designation from the FDA.^* The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla's Khosla Ventures, Eric Schmidt's Innovation Endeavors, Jerry Yang's AME Cloud Ventures, and Philip Liang's E15 VC. The Company is headquartered in Waltham, MA.

Investor Inquiries:
Mike Piccinino, CFA
Mike.Piccinino@westwicke.com

Press and Media Inquiries:
Sean Leous
Sean.Leous@westwicke.com
Phone + 1 646 866 4012

^* As of the date of this press release, Vicarious Surgical is not aware of any surgical robotics company that has announced receiving Breakthrough Designation for a full robotics system.

View original content to download multimedia:http://www.prnewswire.com/news-releases/vicarious-surgical-to-present-at-the-cowen-6th-annual-futurehealth-conference-on-june-17th-301310976.html

SOURCE Vicarious Surgical

FAQ

When will Vicarious Surgical present at the Cowen 6th Annual FutureHealth Conference?

Vicarious Surgical will present at the Cowen 6th Annual FutureHealth Conference on June 17, 2021.

Who is participating in the fireside chat at the conference?

CEO Adam Sachs will participate in the fireside chat on June 17, 2021.

What time is Vicarious Surgical's presentation at the Cowen Conference?

The presentation is scheduled for 10:00 a.m. Eastern Time.

How can I access the live audio webcast of Vicarious Surgical's presentation?

The live audio webcast can be accessed on Vicarious Surgical's website.

What is the significance of the FDA Breakthrough Device Designation for Vicarious Surgical?

The Breakthrough Device Designation signifies that Vicarious Surgical is the first surgical robot to receive this designation, highlighting its innovative technology.